Newron Pharmaceuticals To Present At The 27th Annual Piper Jaffray Healthcare Conference
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) [Ticker: SIX: NWRN], a research and development company focused on novel central nervous system (CNS) and pain therapies, today announced that Stefan Weber, CEO, will present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on Dec. 1, 2015, at 11:50 a.m. ET at the New York Palace Hotel.